Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18443575rdf:typepubmed:Citationlld:pubmed
pubmed-article:18443575lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18443575lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:18443575lifeskim:mentionsumls-concept:C0022658lld:lifeskim
pubmed-article:18443575lifeskim:mentionsumls-concept:C0018787lld:lifeskim
pubmed-article:18443575lifeskim:mentionsumls-concept:C0067385lld:lifeskim
pubmed-article:18443575lifeskim:mentionsumls-concept:C0857121lld:lifeskim
pubmed-article:18443575pubmed:issue6lld:pubmed
pubmed-article:18443575pubmed:dateCreated2008-5-26lld:pubmed
pubmed-article:18443575pubmed:abstractTextDespite the frequent simultaneous presentation of cardiac and renal dysfunction, the relationship between these pathophysiological processes remains unclear. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide (NO) synthase, which has been linked to endothelial dysfunction and atherosclerosis. This study elucidates the relationship between ADMA and intrarenal and coronary microvascular diseases.lld:pubmed
pubmed-article:18443575pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18443575pubmed:languageenglld:pubmed
pubmed-article:18443575pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18443575pubmed:citationSubsetIMlld:pubmed
pubmed-article:18443575pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18443575pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18443575pubmed:statusMEDLINElld:pubmed
pubmed-article:18443575pubmed:monthJunlld:pubmed
pubmed-article:18443575pubmed:issn0895-7061lld:pubmed
pubmed-article:18443575pubmed:authorpubmed-author:KawanoYuheiYlld:pubmed
pubmed-article:18443575pubmed:authorpubmed-author:FujiiHidekiHlld:pubmed
pubmed-article:18443575pubmed:authorpubmed-author:FukagawaMasaf...lld:pubmed
pubmed-article:18443575pubmed:authorpubmed-author:TakiuchiShinSlld:pubmed
pubmed-article:18443575pubmed:issnTypePrintlld:pubmed
pubmed-article:18443575pubmed:volume21lld:pubmed
pubmed-article:18443575pubmed:ownerNLMlld:pubmed
pubmed-article:18443575pubmed:authorsCompleteYlld:pubmed
pubmed-article:18443575pubmed:pagination650-6lld:pubmed
pubmed-article:18443575pubmed:dateRevised2009-2-24lld:pubmed
pubmed-article:18443575pubmed:meshHeadingpubmed-meshheading:18443575...lld:pubmed
pubmed-article:18443575pubmed:meshHeadingpubmed-meshheading:18443575...lld:pubmed
pubmed-article:18443575pubmed:meshHeadingpubmed-meshheading:18443575...lld:pubmed
pubmed-article:18443575pubmed:meshHeadingpubmed-meshheading:18443575...lld:pubmed
pubmed-article:18443575pubmed:meshHeadingpubmed-meshheading:18443575...lld:pubmed
pubmed-article:18443575pubmed:meshHeadingpubmed-meshheading:18443575...lld:pubmed
pubmed-article:18443575pubmed:meshHeadingpubmed-meshheading:18443575...lld:pubmed
pubmed-article:18443575pubmed:meshHeadingpubmed-meshheading:18443575...lld:pubmed
pubmed-article:18443575pubmed:meshHeadingpubmed-meshheading:18443575...lld:pubmed
pubmed-article:18443575pubmed:meshHeadingpubmed-meshheading:18443575...lld:pubmed
pubmed-article:18443575pubmed:meshHeadingpubmed-meshheading:18443575...lld:pubmed
pubmed-article:18443575pubmed:meshHeadingpubmed-meshheading:18443575...lld:pubmed
pubmed-article:18443575pubmed:year2008lld:pubmed
pubmed-article:18443575pubmed:articleTitlePutative role of asymmetric dimethylarginine in microvascular disease of kidney and heart in hypertensive patients.lld:pubmed
pubmed-article:18443575pubmed:affiliationDivision of Nephrology and Kidney Center, Kobe University Graduate School of Medicine, Kobe, Japan.lld:pubmed
pubmed-article:18443575pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18443575pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18443575lld:pubmed